Abstract
Paediatric central nervous system tumours are a leading cause of cancer-related mortality and morbidity in high-income countries. Limited data are available concerning the incidence of these tumours in low-income countries, due to lack of proper cancer registries and shortage of publications. The management of childhood brain tumours face several challenges in countries with limited resources. Delayed presentation, insufficient number of specialists (paediatric neurosurgeons, paediatric oncologists and radiation oncologists), shortage of radiological diagnostic tools like MRI, of neurosurgical equipment or radiation machines are significant obstacles. In addition, abandonment of treatment and loss of follow-up are common, mostly for social or economic reasons. Paediatric neuro-oncology is relatively a new subspecialty and requires close multidisciplinary team work. This concept is not emphasized in many develo** countries. Some of these difficulties can be managed by enriching the resources through international collaborations; others may need shared experience with more advanced countries through twinning programs. Successful experiences have been conducted in the recent years that demonstrate the possibility to improve the care of children with brain tumours in countries with limited resources.
Access this chapter
Tax calculation will be finalised at checkout
Purchases are for personal use only
Similar content being viewed by others
References
Ribeiro RC, Steliarova-Foucher E, Magrath I, Lemerle J, Eden T, Forget C, et al. Baseline status of paediatric oncology care in ten low-income or mid-income countries receiving My Child Matters support: a descriptive study. Lancet Oncol. 2008;9(8):721–9. Epub 2008/08/02.
Asirvatham JR, Deepti AN, Chyne R, Prasad MS, Chacko AG, Rajshekhar V, et al. Pediatric tumors of the central nervous system: a retrospective study of 1,043 cases from a tertiary care center in South India. Childs Nerv Syst. 2011;27(8):1257–63. Epub 2011/02/24.
Ahmed N, Bhurgri Y, Sadiq S, Shakoor KA. Pediatric brain tumours at a tertiary care hospital in Karachi. Asian Pac J Cancer Prev. 2007;8(3):399–404. Epub 2007/12/28.
Katchy KC, Mallik AA, Al-Nashmi NM, Joseph E, Alexander S, Al-Ramadan A. Intracranial tumors in Kuwait: a 15-year survey. J Neurooncol. 2011;104(1):271–7. Epub 2010/12/08.
Curado MP, Voti L, Sortino-Rachou AM. Cancer registration data and quality indicators in low and middle income countries: their interpretation and potential use for the improvement of cancer care. Cancer Causes Control. 2009;20(5):751–6. Epub 2008/12/30.
Howard SC, Metzger ML, Wilimas JA, Quintana Y, Pui CH, Robison LL, et al. Childhood cancer epidemiology in low-income countries. Cancer. 2008;112(3):461–72. Epub 2007/12/12.
Valsecchi MG, Steliarova-Foucher E. Cancer registration in develo** countries: luxury or necessity? Lancet Oncol. 2008;9(2):159–67. Epub 2008/02/02.
Al-Hadad SA, Al-Jadiry MF, Al-Darraji AF, Al-Saeed RM, Al-Badr SF, Ghali HH. Reality of pediatric cancer in Iraq. J Pediatr Hematol Oncol. 2011;33 Suppl 2:S154–6. Epub 2011/10/05.
Usmani GN. Pediatric oncology in the third world. Curr Opin Pediatr. 2001;13(1):1–9. Epub 2001/02/15.
Dolecek TA, Propp JM, Stroup NE, Kruchko C. CBTRUS statistical report: primary brain and central nervous system tumors diagnosed in the United States in 2005–2009. Neuro Oncol. 2012;14 Suppl 5:v1–49. Epub 2012/11/01.
Manoharan N, Julka PK, Rath GK. Descriptive epidemiology of primary brain and CNS tumors in Delhi, 2003–2007. Asian Pac J Cancer Prev. 2012;13(2):637–40. Epub 2012/04/25.
Wilne S, Collier J, Kennedy C, Koller K, Grundy R, Walker D. Presentation of childhood CNS tumours: a systematic review and meta-analysis. Lancet Oncol. 2007;8(8):685–95. Epub 2007/07/24.
Dang-Tan T, Franco EL. Diagnosis delays in childhood cancer: a review. Cancer. 2007;110(4):703–13. Epub 2007/07/11.
El-Fiki M. African neurosurgery, the 21st-century challenge. World Neurosurg. 2010;73(4):254–8. Epub 2010/09/21.
Ariffin H, Abdullah WA, de Bruyne J, Lee CL, Peng LH. Belief in traditional healers amongst Malaysian parents of children with cancer. J Trop Pediatr. 1997;43(6):375–6. Epub 1998/02/26.
Hamidah A, Rustam ZA, Tamil AM, Zarina LA, Zulkifli ZS, Jamal R. Prevalence and parental perceptions of complementary and alternative medicine use by children with cancer in a multi-ethnic Southeast Asian population. Pediatr Blood Cancer. 2009;52(1):70–4. Epub 2008/10/22.
Daher M. Cultural beliefs and values in cancer patients. Ann Oncol. 2012;23 Suppl 3:66–9. Epub 2012/06/01.
Bhopal SS, Mann KD, Pearce MS. Registration of cancer in girls remains lower than expected in countries with low/middle incomes and low female education rates. Br J Cancer. 2012;107(1):183–8. Epub 2012/05/12.
Mostert S, Arora RS, Arreola M, Bagai P, Friedrich P, Gupta S, et al. Abandonment of treatment for childhood cancer: position statement of a SIOP PODC Working Group. Lancet Oncol. 2011;12(8):719–20. Epub 2011/07/02.
Nadkarni TD, Goel A, Pandya SK. Neurosurgery in India. J Postgrad Med. 2002;48(4):332–5. Epub 2003/02/07.
El Khamlichi A. African neurosurgery: current situation, priorities, and needs. Neurosurgery. 2001;48(6):1344–7. Epub 2001/06/01.
Zeltzer PM, Boyett JM, Finlay JL, Albright AL, Rorke LB, Milstein JM, et al. Metastasis stage, adjuvant treatment, and residual tumor are prognostic factors for medulloblastoma in children: conclusions from the Children’s Cancer Group 921 randomized phase III study. J Clin Oncol. 1999;17(3):832–45.
Bouffet E, Perilongo G, Canete A, Massimino M. Intracranial ependymomas in children: a critical review of prognostic factors and a plea for cooperation. Med Pediatr Oncol. 1998;30(6):319–29; discussion 29–31.
Dwarakanath S, Suri A, Sharma BS, Mahapatra AK. Neuronavigation in a develo** country: a pilot study of efficacy and limitations in intracranial surgery. Neurol India. 2007;55(2):111–6. Epub 2007/06/15.
Qaddoumi I, Mansour A, Musharbash A, Drake J, Swaidan M, Tihan T, et al. Impact of telemedicine on pediatric neuro-oncology in a develo** country: the Jordanian-Canadian experience. Pediatr Blood Cancer. 2007;48(1):39–43.
Berezowska S, Tomoka T, Kamiza S, Milner Jr DA, Langer R. Surgical pathology in sub-Saharan Africa–volunteering in Malawi. Virchows Arch. 2012;460(4):363–70. Epub 2012/03/13.
Judkins AR. Immunohistochemistry of INI1 expression: a new tool for old challenges in CNS and soft tissue pathology. Adv Anat Pathol. 2007;14(5):335–9. Epub 2007/08/25.
Lannering B, Rutkowski S, Doz F, Pizer B, Gustafsson G, Navajas A, et al. Hyperfractionated versus conventional radiotherapy followed by chemotherapy in standard-risk medulloblastoma: results from the randomized multicenter HIT-SIOP PNET 4 trial. J Clin Oncol. 2012;30(26):3187–93. Epub 2012/08/02.
Packer RJ, Gajjar A, Vezina G, Rorke-Adams L, Burger PC, Robertson PL, et al. Phase III study of craniospinal radiation therapy followed by adjuvant chemotherapy for newly diagnosed average-risk medulloblastoma. J Clin Oncol. 2006;24(25):4202–8.
Merchant TE, Li C, **ong X, Kun LE, Boop FA, Sanford RA. Conformal radiotherapy after surgery for paediatric ependymoma: a prospective study. Lancet Oncol. 2009;10(3):258–66. Epub 2009/03/11.
Bouffet E, Baranzelli MC, Patte C, Portas M, Edan C, Chastagner P, et al. Combined treatment modality for intracranial germinomas: results of a multicentre SFOP experience. Societe Francaise d’Oncologie Pediatrique. Br J Cancer. 1999;79(7–8):1199–204.
Levin CV, El Gueddari B, Meghzifene A. Radiation therapy in Africa: distribution and equipment. Radiother Oncol. 1999;52(1):79–84. Epub 1999/11/30.
Carrie C, Alapetite C, Mere P, Aimard L, Pons A, Kolodie H, et al. Quality control of radiotherapeutic treatment of medulloblastoma in a multicentric study: the contribution of radiotherapy technique to tumour relapse. The French Medulloblastoma Group. Radiother Oncol. 1992;24(2):77–81. Epub 1992/06/01.
Zaghloul M, Ahmed S, Eldebaway E, Mousa A, Amin A, Elkhateeb N, et al. Hypofractionated radiotherapy for pediatric diffuse intrinsic pontine glioma (DIPG): a prospective controled randomized trial. Neuro Oncol. 2012:i26.
Ronghe M, Hargrave D, Bartels U, Tabori U, Vaidya S, Chandler C, et al. Vincristine and carboplatin chemotherapy for unresectable and/or recurrent low-grade astrocytoma of the brainstem. Pediatr Blood Cancer. 2010;55(3):471–7. Epub 2010/06/11.
Scheinemann K, Bartels U, Huang A, Hawkins C, Kulkarni AV, Bouffet E, et al. Survival and functional outcome of childhood spinal cord low-grade gliomas. Clinical article. J Neurosurg Pediatr. 2009;4(3):254–61. Epub 2009/09/24.
Reddy AT, Packer RJ. Chemotherapy for low-grade gliomas. Childs Nerv Syst. 1999;15(10):506–13. Epub 1999/11/07.
Pollack IF. Multidisciplinary management of childhood brain tumors: a review of outcomes, recent advances, and challenges. J Neurosurg Pediatr. 2011;8(2):135–48. Epub 2011/08/03.
Sievert AJ, Fisher MJ. Pediatric low-grade gliomas. J Child Neurol. 2009;24(11):1397–408. Epub 2009/10/21.
Packer RJ, Ater J, Allen J, Phillips P, Geyer R, Nicholson HS, et al. Carboplatin and vincristine chemotherapy for children with newly diagnosed progressive low-grade gliomas. J Neurosurg. 1997;86(5):747–54.
Prados MD, Edwards MS, Rabbitt J, Lamborn K, Davis RL, Levin VA. Treatment of pediatric low-grade gliomas with a nitrosourea-based multiagent chemotherapy regimen. J Neurooncol. 1997;32(3):235–41.
Massimino M, Spreafico F, Cefalo G, Riccardi R, Tesoro-Tess JD, Gandola L, et al. High response rate to cisplatin/etoposide regimen in childhood low-grade glioma. J Clin Oncol. 2002;20(20):4209–16.
Bouffet E, Jakacki R, Goldman S, Hargrave D, Hawkins C, Shroff M, et al. Phase II study of weekly vinblastine in recurrent or refractory pediatric low-grade glioma. J Clin Oncol. 2012;30(12):1358–63. Epub 2012/03/07.
Cappellano AM, Bouffet E, Silva F, Paiva P, Alves M, Cavalheiro S, et al. Vinorelbine in progressive unresectable low-grade glioma in children. J Clin Oncol. 2011;29(15S):591.
Scheinemann K, Bartels U, Tsangaris E, Hawkins C, Huang A, Dirks P, et al. Feasibility and efficacy of repeated chemotherapy for progressive pediatric low-grade gliomas. Pediatr Blood Cancer. 2011;57(1):84–8. Epub 2010/12/03.
Jakacki RI, Burger PC, Zhou T, Holmes EJ, Kocak M, Onar A, et al. Outcome of children with metastatic medulloblastoma treated with carboplatin during craniospinal radiotherapy: a Children’s Oncology Group Phase I/II study. J Clin Oncol. 2012;30(21):2648–53. Epub 2012/06/06.
Souweidane MM, Bouffet E, Finlay J. The role of chemotherapy in newly diagnosed ependymoma of childhood. Pediatr Neurosurg. 1998;28(5):273–8.
Grundy RG, Wilne SA, Weston CL, Robinson K, Lashford LS, Ironside J, et al. Primary postoperative chemotherapy without radiotherapy for intracranial ependymoma in children: the UKCCSG/SIOP prospective study. Lancet Oncol. 2007;8(8):696–705.
Grill J, Pascal C, Chantal K. Childhood ependymoma: a systematic review of treatment options and strategies. Paediatr Drugs. 2003;5(8):533–43. Epub 2003/08/05.
Laughton SJ, Merchant TE, Sklar CA, Kun LE, Fouladi M, Broniscer A, et al. Endocrine outcomes for children with embryonal brain tumors after risk-adapted craniospinal and conformal primary-site irradiation and high-dose chemotherapy with stem-cell rescue on the SJMB-96 trial. J Clin Oncol. 2008;26(7):1112–8. Epub 2008/03/04.
Qaddoumi I, Unal E, Diez B, Kebudi R, Quintana Y, Bouffet E, et al. Web-based survey of resources for treatment and long-term follow-up for children with brain tumors in develo** countries. Childs Nerv Syst. 2011;27(11):1957–61. Epub 2011/05/18.
Koshy RC, Rhodes D, Devi S, Grossman SA. Cancer pain management in develo** countries: a mosaic of complex issues resulting in inadequate analgesia. Support Care Cancer. 1998;6(5):430–7. Epub 1998/10/17.
Delgado E, Barfield RC, Baker JN, Hinds PS, Yang J, Nambayan A, et al. Availability of palliative care services for children with cancer in economically diverse regions of the world. Eur J Cancer. 2010;46(12):2260–6. Epub 2010/06/15.
Qaddoumi I, Ezam N, Swaidan M, Jaradat I, Mansour A, Abuirmeileh N, et al. Diffuse pontine glioma in Jordan and impact of up-front prognosis disclosure with parents and families. J Child Neurol. 2009;24(4):460–5. Epub 2008/12/17.
Howard SC, Pedrosa M, Lins M, Pedrosa A, Pui CH, Ribeiro RC, et al. Establishment of a pediatric oncology program and outcomes of childhood acute lymphoblastic leukemia in a resource-poor area. JAMA. 2004;291(20):2471–5. Epub 2004/05/27.
Qaddoumi I, Musharbash A, Elayyan M, Mansour A, Al-Hussaini M, Drake J, et al. Closing the survival gap: implementation of medulloblastoma protocols in a low-income country through a twinning program. Int J Cancer. 2008;122(6):1203–6. Epub 2007/11/07.
Baskin JL, Lezcano E, Kim BS, Figueredo D, Lassaletta A, Perez-Martinez A, et al. Management of children with brain tumors in Paraguay. Neuro Oncol. 2013;15(2):235–41. Epub 2012/12/01.
Author information
Authors and Affiliations
Corresponding author
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 2014 Springer Science+Business Media New York
About this chapter
Cite this chapter
Amayiri, N., Bouffet, E. (2014). Paediatric Neuro-Oncology. In: Stefan, D., Rodriguez-Galindo, C. (eds) Pediatric Hematology-Oncology in Countries with Limited Resources. Springer, New York, NY. https://doi.org/10.1007/978-1-4614-3891-5_25
Download citation
DOI: https://doi.org/10.1007/978-1-4614-3891-5_25
Published:
Publisher Name: Springer, New York, NY
Print ISBN: 978-1-4614-3890-8
Online ISBN: 978-1-4614-3891-5
eBook Packages: MedicineMedicine (R0)